Catheter Precision, Inc. (NYSEAMERICAN:VTAK – Get Free Report) traded down 3.6% during mid-day trading on Monday . The company traded as low as $0.37 and last traded at $0.39. 118,476 shares changed hands during trading, a decline of 81% from the average session volume of 622,799 shares. The stock had previously closed at $0.40.
Catheter Precision Trading Down 3.6 %
The company has a debt-to-equity ratio of 0.12, a current ratio of 0.66 and a quick ratio of 0.65.
About Catheter Precision
Catheter Precision, Inc designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company’s lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures.
Read More
- Five stocks we like better than Catheter Precision
- Roth IRA Calculator: Calculate Your Potential Returns
- How to Invest in Small Cap Stocks
- Profitably Trade Stocks at 52-Week Highs
- These Are the Dividend Stocks Insiders Bought in January
- How to trade using analyst ratings
- How the ‘No Buy’ Trend of 2025 Is Boosting These 3 Stocks
Receive News & Ratings for Catheter Precision Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catheter Precision and related companies with MarketBeat.com's FREE daily email newsletter.
